Author Correction: A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability
NPJ Vaccines
.
2022 Nov 23;7(1):150.
doi: 10.1038/s41541-022-00578-7.
Authors
Emily A Voigt
1
,
Alana Gerhardt
2
,
Derek Hanson
3
,
Madeleine F Jennewein
3
,
Peter Battisti
3
,
Sierra Reed
2
,
Jasneet Singh
3
,
Raodoh Mohamath
4
,
Julie Bakken
3
,
Samuel Beaver
3
,
Christopher Press
2
,
Patrick Soon-Shiong
5
,
Christopher J Paddon
6
,
Christopher B Fox
4
7
,
Corey Casper
3
2
4
7
8
9
Affiliations
1
RNA Vaccines, Access to Advanced Health Institute (AAHI), Seattle, WA, 98102, USA. emily.voigt@aahi.org.
2
Product Development, Access to Advanced Health Institute (AAHI), Seattle, WA, 98102, USA.
3
RNA Vaccines, Access to Advanced Health Institute (AAHI), Seattle, WA, 98102, USA.
4
Formulation Sciences, Access to Advanced Health Institute (AAHI), Seattle, WA, 98102, USA.
5
ImmunityBio, Inc, Culver City, CA, 90232, USA.
6
Amyris, Inc, Emeryville, CA, 94608, USA.
7
Department of Global Health, University of Washington, Seattle, WA, 98195, USA.
8
Department of Medicine, University of Washington, Seattle, WA, 98195, USA.
9
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA.
PMID:
36418864
PMCID:
PMC9684560
DOI:
10.1038/s41541-022-00578-7
No abstract available
Publication types
Published Erratum